Literature DB >> 2490832

Changes in hypertension treatment and in congestive heart failure mortality in the United States.

S Yusuf1, T Thom, R D Abbott.   

Abstract

The use of antihypertensive agents has increased in recent years and has been more marked among individuals in older age groups (65-74 years) than in middle-aged groups (45-54 years). Because hypertension is a strong risk factor for the development of congestive heart failure, more common use of antihypertensive agents would be expected to reduce the incidence of congestive heart failure. Examination of the national death statistics reveals decreases in congestive heart failure mortality at younger ages with mortality increases at older ages. The reasons for these divergent trends in congestive heart failure mortality in different ages and the apparent inconsistency with respect to the changes in the use of antihypertensive drugs are explored. We speculate that antihypertensive treatment does not completely prevent congestive heart failure but merely postpones its development by several decades.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2490832     DOI: 10.1161/01.hyp.13.5_suppl.i74

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  Hypertension, hypertrophy, heart failure.

Authors:  M G Nicholls
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 2.  Exercise for patients with congestive heart failure.

Authors:  R J Shephard
Journal:  Sports Med       Date:  1997-02       Impact factor: 11.136

3.  The World Health Organization--International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration: prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments.

Authors:  B Neal; S MacMahon
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 4.  Epidemiology and risk profile of heart failure.

Authors:  Anh L Bui; Tamara B Horwich; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2010-11-09       Impact factor: 32.419

5.  Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.

Authors:  J B Reitsma; A Mosterd; A J de Craen; R W Koster; F J van Capelle; D E Grobbee; J G Tijssen
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

6.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.

Authors:  Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima
Journal:  Arch Intern Med       Date:  2008-10-27

Review 7.  Epidemiology and aetiology of heart failure.

Authors:  Boback Ziaeian; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2016-03-03       Impact factor: 32.419

8.  Evaluation of Hypertension Prevention and Control Programs in Lima, Peru.

Authors:  Bonhee Chung; Dohyeong Kim; Eun Woo Nam
Journal:  Osong Public Health Res Perspect       Date:  2018-01

Review 9.  An overview of hypertension and cardiac involvement in Asia: Focus on heart failure.

Authors:  Arieska Ann Soenarta; Peera Buranakitjaroen; Yook-Chin Chia; Chen-Huan Chen; Jennifer Nailes; Satoshi Hoshide; Huynh Van Minh; Sungha Park; Jinho Shin; Saulat Siddique; Jorge Sison; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Narsingh Verma; Tzung-Dau Wang; Yu-Qing Zhang; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.